Physician profile
Jennifer Howell Welle
NPI 1609040518
$32,630.99
in general payments reported to CMS, 2019-2025
26 companies · $2,568 in 2025
The $2,568 reported for 2025 was more than what 95% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,417 · 2020: $4,284 · 2021: $3,243 · 2022: $4,717 · 2023: $5,742 · 2024: $8,660 · 2025: $2,568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $15K · Food and Beverage: $1,699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $15,271.00 |
| Food and Beverage | $1,698.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $20,945.91 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $8,667.80 | 2019-2025 | Gardasil 9, Gardasil |
| Hologic Sales and Service, LLC | $1,121.69 | 2019-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Abbvie INC. | $454.20 | 2019-2025 | |
| Biogen, INC. | $202.09 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $157.14 | 2023-2025 | Veozah |
| Myovant Sciences INC. | $156.49 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $155.92 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $97.21 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $94.23 | 2019-2021 | |
| Coopersurgical, INC. | $82.45 | 2022-2025 | Paragard T 380a, Supercut Hysterectomy Scissors |
| Boston Scientific Corporation | $77.21 | 2021-2025 | Solyx Sis System, Farapulse |
| Daiichi Sankyo INC. | $66.78 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $50.03 | 2021-2023 | |
| Exeltis, USA INC. | $42.12 | 2019-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $35.53 | 2019-2020 | |
| Pfizer INC. | $35.24 | 2022-2023 | |
| Momentis Surgical INC. | $30.00 | 2022 | |
| Amag Pharmaceuticals, INC. | $28.74 | 2019 | |
| Lupin INC. | $27.85 | 2020-2021 | |
| Intuitive Surgical, INC. | $25.22 | 2022 | |
| Becton, Dickinson and Company | $20.55 | 2022 | |
| Smith+Nephew, INC. | $18.06 | 2025 | Pico 7, "Acticoat 4"" X 4""" |
| Evofem Biosciences, INC. | $14.42 | 2021 | |
| Minerva Surgical, INC | $12.08 | 2019 | |
| Trevena, INC. | $12.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Howell Welle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.